Average of confirmed sales; the main valuation baseline.
Lowest active listing; an asking price, not a completed sale.
Reference-price movement; low volume can make it unstable.
More sales reduce the impact of individual transactions.
Sales answer “what is it worth”; listings answer “what does an available copy cost”.
| DATE | SOURCE | Price | Change |
|---|---|---|---|
| 2026-10-15 | Sold | €0.56 | -5.1% |
| 2026-10-11 | Sold | €0.59 | -4.8% |
| 2026-10-11 | List | €0.63 | -48.8% |
| 2026-09-13 | Sold | €0.62 | — |
| 2026-09-12 | Sold | €0.62 | — |
| 2026-09-12 | List | €1.23 | — |
| 2026-09-11 | Sold | €0.62 | — |
| 2026-09-11 | List | €1.23 | +92.2% |
| 2026-09-10 | Sold | €0.62 | — |
| 2026-09-10 | List | €0.64 | -57.3% |
| 2026-09-09 | List | €1.50 | +22.0% |
| 2026-09-08 | Sold | €0.62 | — |
| 2026-09-08 | List | €1.23 | — |
| 2026-09-07 | List | €1.23 | -0.8% |
Facing a New Trial / #019
Italy: lowest · France: above average · EU average €1.20Choose a region above to inspect its prices and history.
DETAILED PRICES · Price History
| Condition/Grade | Price | LOW | HIGH | 7D CHG | Volume | Spark |
|---|---|---|---|---|---|---|
AggregatedRAW | €0.56 | €0.20 | €0.62 | -9.7% | >5 | |
NMRAW | €0.56 | €0.20 | €0.62 | -48.6% | >5 |
Explore Electabuzz (sm2+ 019) Facing a New Trial JP #019, Normal from Facing a New Trial, with 155 price records for the EU market. Prices above are labeled by source, currency and condition. Asking prices and recorded sales are different measures, not interchangeable valuations.